News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Ecron Acunova Strengthens Clinical Research Presence in Nordic Countries by Acquiring Majority Stake in aCROnordic
March 28, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
FRANKFURT, Germany--(BUSINESS WIRE)--Ecron Acunova (EA), a full-service expert CRO with well-directed multi-continental spread, announced acquisition of majority stake of aCROnordic, a CRO specialised in clinical research in Nordic countries.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Europe
MORE ON THIS TOPIC
Rare diseases
Amylyx Axes Drug Program for Rare Neurodegenerative Disorder
August 27, 2025
·
2 min read
·
Tristan Manalac
Neuroscience
Novartis, BioArctic Partner To Penetrate the Blood-Brain Barrier
August 27, 2025
·
1 min read
·
Tristan Manalac
Layoff Tracker
Appia Shuts Down Before Reaching Clinic
August 27, 2025
·
191 min read
·
BioSpace Editorial Staff
Layoffs
Pfizer Cuts 100 From Former Seagen HQ Amid ‘Digital Enablement and Automation’ Push
August 27, 2025
·
2 min read
·
Tristan Manalac